MedPath

TEQUIN IV

TEQUIN IV

Discontinued
DIN Number

02243184

Drug Class

Human

Market Date

Mar 14, 2001

Company
HC

bristol-myers squibb canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02243184
AIG Number0142621004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J01MA16 GATIFLOXACIN
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification08:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

GATIFLOXACINActive
Strength: 10 MG / ML
Monograph: GATIFLOXACIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.